| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net income/(loss) | -727,133 | -331,739 |
| Depreciation and amortization | 1,329 | 695 |
| Discount expensed from note payable and convertible notes | 21,360 | 4,999 |
| Common stock issued for services | -384,150 | -34,169 |
| Warrants issued for services | 187,464 | 95,152 |
| Change in fair value on derivative liability | 67,423 | -53,468 |
| Accounts receivable | 20,260 | -7,024 |
| Deposit | 6,474 | - |
| Inventory | -394,694 | -254,337 |
| Note receivable | 391,890 | 100,000 |
| Offering costs | 0 | 0 |
| Right of use asset, net - current | 8,984 | 8,984 |
| Right of use asset, net - non-current | -166,086 | -180,811 |
| Accounts payable | 69,103 | 62,641 |
| Accrued liabilities | -85,913 | -24,613 |
| Accrued interest payable | 7,210 | 7,072 |
| Accrued interest payable - related party | 29,740 | 13,240 |
| Lease liability - current | 53,293 | 50,858 |
| Lease liability - long-term | 105,219 | 121,761 |
| Net cash provided by (used in) operating activities | -202,634 | 77,237 |
| Loan origination fees | - | 0 |
| Fixed asset purchase | 19,302 | 19,302 |
| Proceeds from issuance of common stock | - | 0 |
| Cash flows provided by (used in) investing activities | -19,302 | -19,302 |
| Proceeds from issuance of convertible debt | 0 | 0 |
| Payments for repayment of convertible debt | 146,904 | 83,437 |
| Proceeds from issuance of noted payable | 160,000 | 160,000 |
| Payments for repayment of notes payable | -56,549 | -8,498 |
| Proceeds from issuance of noted payable - related party | 400,000 | 0 |
| Payments for repayment of noted payable - related party | 57,179 | 37,524 |
| Net cash provided by (used in) financing activities | 299,368 | 30,539 |
| Increase (decrease) in cash | 77,432 | 88,475 |
| Cash and cash equivalents at beginning of period | 112,020 | - |
| Cash and cash equivalents at end of period | 189,452 | - |
HEALTHY EXTRACTS INC. (HYEX)
HEALTHY EXTRACTS INC. (HYEX)